Patent · US Active

Modified polynucleotides encoding aquaporin-5

US9220792B2 · kind B2 · utility

89Cited by

399References

7Claims

0Family size

Assignee

Moderna Therapeutics, Inc. · US

Inventors

Tirtha Chakraborty · Medford, US
Antonin de Fougerolles · Waterloo, BE

Key dates

Filing date	Dec 11, 2013
Grant date	Dec 29, 2015
Priority date	—
Expiry date	Dec 11, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and modified mRNA (mmRNA) molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.